-
公开(公告)号：KR1020090117454A
公开(公告)日：2009-11-12
申请号：KR1020080043504
申请日：2008-05-09
Applicant: 아주대학교산학협력단
Abstract: PURPOSE: A compound isolated from Oenanthe javanica extract is provided to ensure antioxidation and skin whitening effects. CONSTITUTION: A composition for skin whitening contains Oenanthe javanica extract as an active ingredient. The composition contains a compound of the chemical formula 5 as an active ingredient. The composition is manufactured in the form of medicinal and pharmaceutical product, functional food or cosmetic product. The medicinal and pharmaceutical product, functional food or cosmetic product contains pharmaceutically or cosmetically acceptable excipient or additive.
Abstract translation: 目的：提供从爪螨属提取物中分离的化合物，以确保抗氧化和皮肤美白效果。 构成：用于皮肤美白的组合物含有作为活性成分的爪蟾提取物。 组合物含有化学式5的化合物作为活性成分。 该组合物以药用和药物，功能性食品或化妆品的形式制造。 药用和药用产品，功能性食品或化妆品包含药学上或化妆品上可接受的赋形剂或添加剂。
-
公开(公告)号：KR1020090117452A
公开(公告)日：2009-11-12
申请号：KR1020080043500
申请日：2008-05-09
Applicant: 아주대학교산학협력단
CPC classification number: C07H15/04 , A61K31/7048 , A61K36/23 , Y10S514/00
Abstract: PURPOSE: A novel compound isolated from Oenanthe javanica is provided to prevent or treat cranial nerve disease such as Alzheimer disease, Parkinson's disease, Huntington disease, and amyotrophic lateral sclerosis. CONSTITUTION: A novel compound isolated from Oenanthe javanica is denoted by the chemical formula 6. The novel compound of the chemical formula 6 is 3-(4-hydroxy-3-methoxyphenyl)propoxy-2-hydroxy-1-(4-hydroxy-3-methoxyphenyl)propyl β-D glucopyranoside A pharmaceutical composition for preventing or treating cranial disease or spine damage contains a compound of the chemical formula 6 as an active ingredient.
Abstract translation: 目的：提供从爪蟾中分离出来的新型化合物，用于预防或治疗颅神经疾病，如阿尔茨海默病，帕金森病，亨廷顿疾病和肌萎缩性侧索硬化症。 化学式6的新化合物是3-（4-羟基-3-甲氧基苯基）丙氧基-2-羟基-1-（4-羟基-3-甲氧基苯基）丙酸， 3-甲氧基苯基）丙基β-D-吡喃葡萄糖苷用于预防或治疗颅脑疾病或脊椎损伤的药物组合物含有化学式6的化合物作为活性成分。
-
Search Results
2
records
(took 0.018 seconds)
